
The Partnership for Safe Medicines would like to thank the following organizations who have volunteered to sponsor our Interchange conference. Please go to their websites to learn more about them.
|
Gold Sponsor: NanoGuardian provides a state-of-the-art, nanotechnology-based defense against pharmaceutical counterfeiting and illegal diversion. Learn more |
|
Silver Sponsor: Lilly makes medicines that help people live longer, healthier, more active lives. Learn more |
|
Silver Sponsor: FFF Enterprises continues to set the standard for patient safety, access and availability to the plasma products, biopharmaceuticals and vaccines that improve the quality of life for the patients who receive them. Learn more |
![]() |
Silver Sponsor: Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. Learn more |
![]() |
Silver Sponsor: Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Learn more |
|
Bronze Sponsor: From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Learn more |
|
Bronze Sponsor: Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group's continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 full-time-equivalent associates and operate in more than 140 countries around the world. Learn more |